In an industry where innovation and precision define progress, Khaled Harb, Chief Executive Officer of Dar Al Dawa for Development and Investment (DAD), stands at the forefront of pharmaceutical leadership across the MENA region. With more than 30 years of executive experience and a proven record of strategic growth, Harb is not just leading an organization—he is shaping the future of regional healthcare.
From his early foundations in science to his current role as a transformative CEO, Harb exemplifies the kind of leadership that blends operational discipline with forward-looking vision, helping position Jordan and the wider region as a center of pharmaceutical excellence.
A Journey Built on Expertise and Education
Harb’s professional ascent began with a Bachelor’s degree in Pharmacy and Pharmaceutical Sciences from the Medical Academy in Sofia, Bulgaria, in 1990. His deep understanding of pharmaceutical science has remained foundational throughout his career. Committed to lifelong learning, he is currently pursuing an Executive MBA at the American University of Beirut (AUB), further enhancing his capabilities in global business strategy and executive leadership.
This dual expertise—scientific and managerial—has empowered Harb to bridge product innovation with commercial strategy, creating sustainable value in highly regulated markets.
Strategic Growth Across Markets
Khaled Harb’s executive journey has taken him through leadership positions at some of the region’s most influential pharmaceutical companies. His 17-year tenure at Hikma Pharmaceuticals gave him critical insights into MENA market dynamics, particularly in sales and marketing leadership.
He later assumed the role of General Manager at Abdulrehman Algosaibi G.T.C in Saudi Arabia, where for over a decade he led major growth initiatives, restructured operations, and strengthened the company’s competitive positioning.
Since January 2022, Harb has been leading Dar Al Dawa, headquartered in Amman, Jordan. Under his leadership, the company has expanded its reach into MENA and Saudi Arabia, delivering consistent revenue growth, regulatory compliance, and product innovation across diverse markets.
Transforming Dar Al Dawa Through Visionary Leadership
As CEO, Harb has redefined the strategic direction of Dar Al Dawa by:
- Expanding regional and global footprints through smart partnerships and market entry strategies
- Elevating operational excellence across manufacturing, distribution, and regulatory pathways
- Fostering a culture of innovation through digital transformation and R&D integration
- Driving sustainability initiatives aligned with global best practices and healthcare impact
- His focus is not merely on commercial expansion but on building systems and teams that lead with purpose and agility.
A passionate advocate for pharmaceutical innovation, Dr. Khaled Harb views Research and development (R&D)not only as a growth engine for Dar Al Dawa but also as a national imperative to elevate Jordan’s position in global healthcare. His strategic focus on R&D reflects a deep commitment to sustainable, science-driven progress in the pharmaceutical industry.
Industry Contributions and Governance
In addition to leading Dar Al Dawa, Harb contributes significantly to the broader pharmaceutical ecosystem:
- Vice Chairman – Jordanian Association of Pharmaceutical Manufacturers (JAPM): Advocating industry innovation, local manufacturing competitiveness, and regulatory reform
- Board Member – Nutridar Jordanian Public Shareholding Company.
- Board Member – Dar Al Dawa for Veterinary and Agricultural Industries.
- Member of the Higher Drug Committee at the Jordanian FDA.
Through these roles, Harb actively promotes sustainable pharmaceutical development and strengthens Jordan’s positioning as a regional pharmaceutical hub.
Leadership Philosophy: Vision, Integrity, and Impact
“In the pharmaceutical industry, innovation and operational excellence are not just goals—they are imperatives. Our responsibility is to deliver products and solutions that improve lives while driving sustainable growth and ethical practices.”
— Khaled Harb
For Harb, leadership is a catalyst for transformation. His style is built on trust, empowerment, and high accountability—ensuring that teams are aligned not just with KPIs, but with a shared vision of societal impact.
Looking Forward: Building a Global Legacy from the MENA Region
With global healthcare needs evolving, Khaled Harb is focused on positioning Dar Al Dawa for long-term international relevance. He continues to lead strategic efforts that:
- Invest in advanced research and development
- Leverage AI and digital tools for smarter operations
- Expand partnerships across emerging and developed markets
- Shape regulatory standards and patient access policies in the region
His goal: to make Dar Al Dawa not only a market leader in the MENA region but a globally respected player in the pharmaceutical landscape.
Inspired proudly honors Khaled Harb as a visionary CEO whose commitment to innovation, ethical leadership, and sustainable growth is transforming healthcare outcomes and industry standards across the MENA region. His legacy is one of impact, inspiration, and intelligent execution—marking him as a defining figure in the future of global pharma.
